These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34782775)

  • 1. Dysregulation of long noncoding RNA MEG3 and NLRC5 expressions in patients with relapsing-remitting multiple sclerosis: is there any correlation?
    Torkamandi S; Bahrami S; Ghorashi T; Dehani M; Bayat H; Hoseini SM; Rezaei S; Soosanabadi M
    Genes Immun; 2021 Dec; 22(7-8):322-326. PubMed ID: 34782775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA MEG3 regulates rheumatoid arthritis by targeting NLRC5.
    Liu YR; Yang L; Xu QQ; Lu XY; Ma TT; Huang C; Li J
    J Cell Physiol; 2019 Aug; 234(8):14270-14284. PubMed ID: 30644097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of glatiramer acetate, IFNβ-1a, fingolimod, and dimethyl fumarate on the expression of T-bet, IFN-γ, and MEG3 in PBMC of RRMS patients.
    Dabbaghi R; Safaralizadeh R; Rahmani S; Barpour N; Hosseinpourfeizi M; Rajabi A; Baradaran B
    BMC Res Notes; 2023 Oct; 16(1):273. PubMed ID: 37845751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MEG3 reverses CCl
    Wu YY; Wu S; Li XF; Luo S; Wang A; Yin SQ; Huang C; Li J
    Eur J Pharmacol; 2021 Nov; 911():174462. PubMed ID: 34536366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression analysis of NF-κB-associated long noncoding RNAs in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients.
    Soltanmoradi S; Tavakolpour V; Moghadasi AN; Kouhkan F
    J Neuroimmunol; 2021 Jul; 356():577602. PubMed ID: 33979709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
    Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
    Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male-specific coordinated changes in expression of miRNA genes, but not other genes within the DLK1-DIO3 locus in multiple sclerosis.
    Baulina N; Kiselev I; Kozin M; Kabaeva A; Boyko A; Favorova O
    Gene; 2022 Aug; 836():146676. PubMed ID: 35714798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA 26a Expression in Peripheral Blood Mononuclear Cells and Correlation with Serum Interleukin-17 in Relapsing-Remitting Multiple Sclerosis Patients.
    Mahmoud FM; ElSheshtawy NM; Zaki WK; Zamzam DM; Fahim NM
    Egypt J Immunol; 2017 Jun; 24(2):71-82. PubMed ID: 29528581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression Analysis of Long Non-coding RNA Lnc-DC in HLA-DRB1*15:01-Negative Patients with Multiple Sclerosis: A Probable Cause for Gender Differences in Multiple Sclerosis Susceptibility?
    Bahrami T; Taheri M; Javadi S; Omrani MD; Karimipour M
    J Mol Neurosci; 2021 Apr; 71(4):821-825. PubMed ID: 32951137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Putative Association of TOB1-AS1 Long Non-coding RNA with Immune Tolerance: A Study on Multiple Sclerosis Patients.
    Dehghanzad R; Pahlevan Kakhki M; Alikhah A; Sahraian MA; Behmanesh M
    Neuromolecular Med; 2020 Mar; 22(1):100-110. PubMed ID: 31482275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of vitamin D receptor-associated long noncoding RNAs in patients with relapsing-remitting multiple sclerosis.
    Naiini MR; Saeidi K; Azarian A; Bahramzadeh K; Nazari-Robati M
    Bratisl Lek Listy; 2024; 125(2):107-112. PubMed ID: 38219064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression Analysis of BDNF Gene and BDNF-AS Long Noncoding RNA in Whole Blood Samples of Multiple Sclerosis Patients: Not Always a Negative Correlation between Them.
    Gharzi V; Gangi M; Sayad A; Mazdeh M; Arsang-Jang S; Taheri M
    Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):548-556. PubMed ID: 30644699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple time-point assessment of lncRNA
    Wang Z; Zhang W; Li S; Chen D; Wang L; Xu B; Li J
    Biomark Med; 2021 Oct; 15(14):1261-1270. PubMed ID: 34488430
    [No Abstract]   [Full Text] [Related]  

  • 14. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Long Non-coding RNA MEG3/miR-let-7c-5p Axis Regulates Ethanol-Induced Hepatic Steatosis and Apoptosis by Targeting NLRC5.
    Wang Q; Li M; Shen Z; Bu F; Yu H; Pan X; Yang Y; Meng X; Huang C; Li J
    Front Pharmacol; 2018; 9():302. PubMed ID: 29692724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of mir-301a in PBMCs of patients with relapsing-remitting multiple sclerosis is associated with reduced NKRF and PIAS3 expression levels and disease activity.
    Tavakolpour V; Shokri G; Naser Moghadasi A; Mozafari Nahavandi P; Hashemi M; Kouhkan F
    J Neuroimmunol; 2018 Dec; 325():79-86. PubMed ID: 30316680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology.
    Zheleznyakova GY; Piket E; Needhamsen M; Hagemann-Jensen M; Ekman D; Han Y; James T; Khademi M; Al Nimer F; Scicluna P; Huang J; Kockum I; Faridani OR; Olsson T; Piehl F; Jagodic M
    Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33879606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis.
    Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Caggiula M; Mirabella M; Tonali PA; Batocchi AP
    Cytokine; 2008 Oct; 44(1):22-5. PubMed ID: 18793860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression analyses of RMRP, DDX5, and RORC in RRMS patients treated with different drugs versus naïve patients and healthy controls.
    Rahmani S; Noorolyai S; Ayromlou H; Khaze Shahgoli V; Shanehbandi D; Baghbani E; Abdoli Shadbad M; Jigari-Asl F; Khamiriyan M; Safaralizadeh R; Baradaran B
    Gene; 2021 Feb; 769():145236. PubMed ID: 33068674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study.
    Derakhshani A; Asadzadeh Z; Baradaran B; Safarpour H; Rahmani S; Leone P; Abdoli Shadbad M; Hosseinkhani N; Ghasemigol M; Ayromlou H; Ahmadi H; Pouya S; Shojaee M; Tabrizi NJ; Miraki Feriz A; Safarzadeh E; Racanelli V
    Biomed Pharmacother; 2022 Apr; 148():112725. PubMed ID: 35183994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.